Viewing Study NCT00295750


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-02-04 @ 8:43 AM
Study NCT ID: NCT00295750
Status: COMPLETED
Last Update Posted: 2012-12-19
First Post: 2006-02-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
Sponsor: Ferring Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate Cancer View